Chemring Detection Systems Awarded $49M For Biological Detection Systems
Chemring Detection Systems ("CDS") a Chemring Group ("Chemring") company, announced a $49M contract award to supply biological detection systems to the US Army and US Navy. The award was made by the Edgewood Contracting Division of the Aberdeen Providing Grounds Contracting Command for over 100 Joint Biological Point Detection Systems (JBPDS) and Initial Fielding Packages. The systems will be installed on Navy ships such as the USS Ross (DDG 71) and in the Stryker Nuclear Biological Chemical Reconnaissance Vehicle (NBCRV).
The Joint Biological Point Detection System (JBPDS) provides automatic detection and identification of airborne biological agents at very low levels, triggers local and remote warning systems, and communicates threat information over standard communication systems. JBPDS is manufactured in CDS' Charlotte, NC facility. The systems are due for delivery between December 2012 and December 2013.
The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments
The JBPDS program is an US Army program managed by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD). The system is the only US Biological Detection system that has been through Whole System Live Agent Test. There are many variants of the JBPDS including Shipboard, HMMWV shelter, trailer and standalone fixed-emplacement. Multiple systems can be networked for command and control from a single operational interface to provide a broad area of surveillance. The JBPDS is available for sale to international customers with an approved US State Department export license.
Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.
Source : Chemring Detection Systems
Nov 16 - 19, 2015 - Washington, United States